Sector Chart Newron Pharmaceuticals S.p.A.
Stocks
NWRN
IT0004147952
Biotechnology & Medical Research
|
Real-time Estimate
Cboe Europe
07:24:43 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 9.095 CHF | +2.88% |
|
+4.38% | -62.01% |
| 10-22 | Newron Pharmaceuticals S.p.A. Completes Enrollment In Pivotal Phase 3 ENIGMA-TRS 1 Study | CI |
| 10-22 | Newron Pharmaceuticals Completes Enrollment for Schizophrenia Drug Late-stage Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 226M | - | ||||
| 64.14B | |||||
| 55.53B | |||||
| 53.03B | |||||
| 45.99B | |||||
| 42.45B |
Select your edition
All financial news and data tailored to specific country editions
